Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Classement en actions #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Prix de l'action
$0.1559364
Dernière synchronisation: 2026-09-18
Capitalisation boursière
$195.17K
Changement (1 jour)
6.60%
Changement (1 an)
-30.91%
Pays
GB
Échange Fusion Antibodies plc (FAB)

Catégorie

Revenus pour Fusion Antibodies plc (FAB)
Revenus en Sep 2025 TTM : $2.15M
Selon les derniers rapports financiers de Fusion Antibodies plc, le chiffre d'affaires actuel de l'entreprise (TTM) est de $2.15M. En 2024, l'entreprise a réalisé un chiffre d'affaires de $1.43M une diminution par rapport à le chiffre d'affaires de l'année 2023, qui était de $3.58M. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Fusion Antibodies plc de 2013 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $2.15M -15.49%
2025 $2.54M 77.00%
2024 $1.43M -59.95%
2023 $3.58M -43.24%
2022 $6.31M 9.89%
2021 $5.74M 18.80%
2020 $4.83M 70.09%
2019 $2.84M -24.66%
2018 $3.77M 57.07%
2017 $2.40M 12.81%
2016 $2.13M 57.86%
2015 $1.35M 11.90%
2014 $1.20M 95.78%
2013 $615.46K 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
$12.62B 588,305.51%
US
$6.02B 280,545.95%
NL
$2.23B 103,744.77%
US
$15.74B 733,726.73%
AU
- -
CH